Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 31501-31550 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06192849
To Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy
PHASE2Recruiting
20 participants
Started: Dec 31, 2023 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT06157619
Vitrification of Oocytes Matured by CAPA-IVM
N/ARecruiting
20 participants
Started: Dec 31, 2023 · Completed: Mar 31, 2025
1 condition2 sponsors1 location
NCT06153719
The Effects of a 12-week Combined Exercise Intervention on the Gut Microbiome of Older Adults
NARecruiting
80 participants
Started: Dec 31, 2023 · Completed: Jun 30, 2024
1 condition2 sponsors1 location
NCT04923828
Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections
N/ARecruiting
2,000 participants
Started: Dec 31, 2023 · Completed: Dec 31, 2026
1 condition8 sponsors1 location
NCT07193849
Zinc Oxide VS MEBO
PHASE4Recruiting
76 participants
Started: Dec 31, 2023 · Completed: Dec 31, 2025
5 conditions1 sponsor2 locations
NCT06163768
Effects of Insulin Resistance in Non-diabetic Acute Coronary Syndrome Patients
NARecruiting
1 participants
Started: Dec 31, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT06165068
Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study
PHASE3Recruiting
174 participants
Started: Dec 31, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT04947033
A Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid Tumors
PHASE1Recruiting
25 participants
Started: Dec 31, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06180174
Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma
PHASE1Recruiting
24 participants
Started: Dec 31, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06151990
Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus
N/ARecruiting
102 participants
Started: Dec 31, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06184243
Home-Based Social Skills Intervention for Young Children With Developmental Delays
NARecruiting
14 participants
Started: Dec 31, 2023 · Completed: Jun 30, 2024
3 conditions1 sponsor1 location
NCT06195124
A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease
EARLY_PHASE1Recruiting
8 participants
Started: Dec 31, 2023 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT06109558
The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC
PHASE1/PHASE2Recruiting
120 participants
Started: Dec 31, 2023 · Completed: Jul 30, 2027
4 conditions1 sponsor1 location
NCT06158269
DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma
PHASE2Recruiting
40 participants
Started: Dec 31, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06222983
Efficacy and Prognosis of Surgical Intervention in Patients With Carotid Artery Stenosis
N/ARecruiting
100 participants
Started: Dec 31, 2023 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT06209034
Intraoperative Optic Nerve Sheath Diameter Changes After Laparoscopic Surgery
NARecruiting
55 participants
Started: Dec 30, 2023 · Completed: Jul 15, 2024
2 conditions1 sponsor2 locations
NCT05636826
Olive Leaf Extracts in the Control of Hypertension
PHASE2/PHASE3Recruiting
500 participants
Started: Dec 30, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06218992
Corneal and Tear Film Changes in Chinese Patients With Type 2 Diabetes
N/ARecruiting
80 participants
Started: Dec 30, 2023 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT05457829
Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of First Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study
PHASE2Recruiting
88 participants
Started: Dec 30, 2023 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT06128772
Utilizing Battlefield Acupuncture to Treat Chronic Pain
NARecruiting
125 participants
Started: Dec 30, 2023 · Completed: Dec 30, 2026
2 conditions2 sponsors1 location
NCT06194968
Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study
N/ARecruiting
1,800 participants
Started: Dec 30, 2023 · Completed: Dec 1, 2026
1 condition2 sponsors16 locations
NCT06164145
Translation, Cross-cultural Adaptation, Reliability, Validity and Responsiveness of Short Form 36 (SF-36) Questionnaire in Stroke Survivors
N/ARecruiting
125 participants
Started: Dec 30, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT06201247
Off-the-shelf CD123 CAR-NK for R/R AML
EARLY_PHASE1Recruiting
12 participants
Started: Dec 30, 2023 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT04336111
Ultrasound Guided Bilateral Retrolaminar Block as Analgesia for Adolescent Idiopathic Scoliosis Correction
NARecruiting
44 participants
Started: Dec 30, 2023 · Completed: Apr 10, 2024
4 conditions1 sponsor1 location
NCT06189495
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease
PHASE2Recruiting
30 participants
Started: Dec 30, 2023 · Completed: Oct 31, 2026
3 conditions2 sponsors4 locations
NCT05746091
Arthroscopic Partial Trapezictomy With Hematoma Distraction in Basal Thumb Arthritis
NARecruiting
24 participants
Started: Dec 30, 2023 · Completed: Dec 5, 2024
1 condition1 sponsor1 location
NCT06143228
Influence of Directional Preference on Movement Coordination Deficits in Individuals With Whiplash Associated Disorders
N/ARecruiting
65 participants
Started: Dec 30, 2023 · Completed: Dec 30, 2024
2 conditions1 sponsor2 locations
NCT06192186
Adebrelimab Combined With SOX Regimen in Preoperative Neoadjuvant Transformation Therapy for Locally Advanced Gastric Adenocarcinoma
PHASE4Recruiting
110 participants
Started: Dec 30, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06279078
Long-term Effect of Steroid on Metabolic Diseases in Asthmatics
N/ARecruiting
20,000 participants
Started: Dec 30, 2023 · Completed: Jun 30, 2025
4 conditions2 sponsors1 location
NCT06230263
Comparative Functional Vision Outcomes: DAILIES TOTAL1 Toric vs. Spherical Lenses in Asian Astigmatic Patients
NARecruiting
39 participants
Started: Dec 30, 2023 · Completed: Apr 1, 2024
1 condition1 sponsor1 location
NCT06169410
Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer
PHASE4Recruiting
140 participants
Started: Dec 30, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05950945
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
PHASE3Recruiting
250 participants
Started: Dec 30, 2023 · Completed: Oct 1, 2027
1 condition2 sponsors84 locations
NCT06232356
Screening for Lung Health by a Mobile Device
N/ARecruiting
275 participants
Started: Dec 30, 2023 · Completed: Oct 31, 2024
2 conditions1 sponsor2 locations
NCT06773663
Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism
PHASE1/PHASE2Recruiting
150 participants
Started: Dec 30, 2023 · Completed: Oct 30, 2026
2 conditions1 sponsor1 location
NCT06217341
Bispectral Index and Emergence Agitation in Spinal Surgeries
N/ARecruiting
60 participants
Started: Dec 29, 2023 · Completed: Apr 29, 2024
3 conditions1 sponsor1 location
NCT06149312
Feasibility of an Advance Care Planning Intervention
NARecruiting
120 participants
Started: Dec 29, 2023 · Completed: Dec 29, 2024
1 condition1 sponsor1 location
NCT06506721
Comparison Between Two Medical Devices for Labor Induction After Previous C-section
NARecruiting
137 participants
Started: Dec 29, 2023 · Completed: Dec 28, 2026
3 conditions1 sponsor1 location
NCT05991193
A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
N/ARecruiting
100 participants
Started: Dec 29, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06137118
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
PHASE1/PHASE2Recruiting
142 participants
Started: Dec 29, 2023 · Completed: Jun 29, 2027
1 condition1 sponsor79 locations
NCT06090539
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
PHASE1/PHASE2Recruiting
308 participants
Started: Dec 29, 2023 · Completed: Oct 28, 2028
1 condition1 sponsor33 locations
NCT05934318
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
NARecruiting
2,960 participants
Started: Dec 29, 2023 · Completed: Dec 30, 2026
6 conditions4 sponsors1 location
NCT06110793
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
PHASE1/PHASE2Recruiting
43 participants
Started: Dec 29, 2023 · Completed: Nov 30, 2026
1 condition2 sponsors7 locations
NCT06236932
"Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, SIDERALE"
NARecruiting
100 participants
Started: Dec 29, 2023 · Completed: Oct 29, 2026
5 conditions5 sponsors4 locations
NCT06216873
Collecting the Results of Multiple Trauma Patients and Find the Correlation of Morality and Mobility
N/ARecruiting
400 participants
Started: Dec 29, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor2 locations
NCT06158087
To Evaluate the Safety and Efficacy of Intracranial Stent Assisted Endovascular Treatment of Intracranial Aneurysms
NARecruiting
130 participants
Started: Dec 29, 2023 · Completed: Jun 20, 2026
1 condition3 sponsors1 location
NCT06196736
A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer
PHASE3Recruiting
432 participants
Started: Dec 29, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06183697
Multi-omics Database Construction of Healthy Korean Volunteers
N/ARecruiting
3,000 participants
Started: Dec 29, 2023 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT06178679
Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)
PHASE3Recruiting
175 participants
Started: Dec 29, 2023 · Completed: Jul 30, 2024
1 condition2 sponsors1 location
NCT06225921
Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas
PHASE1Recruiting
6 participants
Started: Dec 29, 2023 · Completed: Jan 15, 2025
1 condition1 sponsor1 location
NCT06170489
A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)
PHASE3Recruiting
185 participants
Started: Dec 28, 2023 · Completed: Sep 30, 2027
1 condition1 sponsor1 location